Evidence map›Paper›PMID 29454141›Full record

Trial reportContemporary clinical trials2018

A cluster randomized pilot trial of a tailored worksite smoking cessation intervention targeting Hispanic/Latino construction workers: Intervention development and research design.

Taghrid Asfar, Alberto J Caban-Martinez, Laura A McClure, Estefania C Ruano-Herreria, Danielle Sierra, G Gilford Clark, Daniel Samano, Noella A Dietz, Kenneth D Ward, Kristopher L Arheart and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Contemporary clinical trials, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Taghrid AsfarDepartment of Public Health Sciences, University of Miami Miller School of Medicine, 1120 NW 14(th) St, 9(th) Floor, Miami, FL 33136, United States. Electronic address: tasfar@miami.edu.
Alberto J Caban-MartinezDepartment of Public Health Sciences, University of Miami Miller School of Medicine, 1120 NW 14(th) St, 9(th) Floor, Miami, FL 33136, United States; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, 1120 NW 14(th) St, 9(th) Floor, Miami, FL 33136, United States.
Laura A McClureSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, 1120 NW 14(th) St, 9(th) Floor, Miami, FL 33136, United States.
Estefania C Ruano-HerreriaDepartment of Public Health Sciences, University of Miami Miller School of Medicine, 1120 NW 14(th) St, 9(th) Floor, Miami, FL 33136, United States.
Danielle SierraDepartment of Public Health Sciences, University of Miami Miller School of Medicine, 1120 NW 14(th) St, 9(th) Floor, Miami, FL 33136, United States.
G Gilford ClarkDepartment of Public Health Sciences, University of Miami Miller School of Medicine, 1120 NW 14(th) St, 9(th) Floor, Miami, FL 33136, United States.
Daniel SamanoDepartment of Public Health Sciences, University of Miami Miller School of Medicine, 1120 NW 14(th) St, 9(th) Floor, Miami, FL 33136, United States.
Noella A DietzBroward Health Systems, 1600 S Andrews Avenue, Fort Lauderdale, FL 33316, United States.
Kenneth D WardSchool of Public Health, The University of Memphis, 201 Robison Hall, Memphis, TN 38152-3480, United States.
Kristopher L ArheartDepartment of Public Health Sciences, University of Miami Miller School of Medicine, 1120 NW 14(th) St, 9(th) Floor, Miami, FL 33136, United States.
David J LeeDepartment of Public Health Sciences, University of Miami Miller School of Medicine, 1120 NW 14(th) St, 9(th) Floor, Miami, FL 33136, United States; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, 1120 NW 14(th) St, 9(th) Floor, Miami, FL 33136, United States.
Broward Health · USUniversity of Memphis · USUniversity of Miami · US

Funding

A Novel Worksite Smoking Cessation intervention for Hispanic Construction WorkersR21CA202993 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LEE, DAVID J · 2016 to 2017
$367k
NCI NIH HHS R21 CA202993
6 · The paper itself

Abstract

Construction workers have the highest smoking rate among all occupations (39%). Hispanic/Latino workers constitute a large and increasing group in the US construction industry (over 2.6 million; 23% of all workers). These minority workers have lower cessation rates compared to other groups due to their limited access to cessation services, and lack of smoking cessation interventions adapted to their culture and work/life circumstances. Formative research was conducted to create an intervention targeting Hispanic/Latino construction workers. This paper describes the intervention development and the design, methods, and data analysis plans for an ongoing cluster pilot two-arm randomized controlled trial comparing an Enhanced Care worksite cessation program to Standard Care. Fourteen construction sites will be randomized to either Enhanced Care or Standard Care and 126 participants (63/arm) will be recruited. In both arms, recruitment and intervention delivery occur around "food trucks" that regularly visit the construction sites. Participants at Enhanced Care sites will receive the developed intervention consisting of a single face-to-face group counseling session, 2 phone calls, and a fax referral to Florida tobacco quitline (QL). Participants at Standard Care sites will receive a fax referral to the QL. Both groups will receive eight weeks of nicotine replacement treatment and two follow-up assessments at three and six months. Feasibility outcomes are estimated recruitment yield, barriers to delivering the intervention onsite, and rates of adherence/compliance to the intervention, follow-ups, and QL enrollment. Efficacy outcomes are point-prevalence and prolonged abstinence rates at six month follow-up confirmed by saliva cotinine <15 ng/ml.

Indexed as

SmokingAdultConstruction IndustryCotinineHispanic or LatinoHumansMalePilot ProjectsResearch DesignSalivaSmoking CessationSmoking PreventionTobacco Use Cessation DevicesCotinineCluster randomized clinical trialFeasiblyFormative researchSmoking cessation interventionTailoredWorksite

Identifiers

PMID29454141
PMCPMC6377564
OpenAlexW2790017527

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.